Novel Nucleic Acid Purification Chemistry
AssigneeBiocartis NV
InventorMax HAESENDONCKX
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiocartis NV
InventorMax HAESENDONCKX
Estimating the term…
The present invention generally relates to the field of nucleic acid isolation on silica solid support. In particular, a novel silica-solid support nucleic acid binding buffer chemistry is hereby disclosed, which is based on the use of a small quaternary organic compounds, e.g. tetramethylammonium chloride (TMAC), at acidic conditions. This novel nucleic acid purification chemistry purifies not only RNA but also DNA and has the potential for being implementable in a wide variety of commercial kits ranging from the spin columns to integrated Lab-On-A-Chip (LOC) devices such as disposable cartridges that make use of a solid-phase extraction technology. Furthermore, the present methods may be performed using relatively small volumes of binding buffer and consequently in such integrated or closed molecular diagnostic devices, they have the potential of allowing increased volumes of sample input, which for liquid biopsy samples such as plasma or urine, can enhance the chances of detecting rare nucleic acid targets.
A nucleic acid extraction method comprising contacting a liquid biopsy sample with a silica solid support at pH value between 3 and 6 and in the presence of a salt consisting of:
A cartridge comprising a binding buffer solution, said binding buffer solution comprising a buffering agent adapted to keeping pH at a value between 3 and 6 and further comprising TMAC.
Dependencies are inferred from the claim text.